Dans le cadre du projet ANR FungiSol porté par Isabelle Ourliac-Garnier et du partenariat avec le Pôle Séquoia de la mairie de Nantes, Rose-Anne Lavergne, Marjorie Albassier, Thomas Ferran et Auriane Fraix animeront un atelier pour des enfants (et leurs parents ), le 22 octobre 2025 de 14h à 17h.

Toutes les informations sont ici : https://metropole.nantes.fr/que-faire-nantes/agenda/atelier-enfants-parents-les-mysteres-du-sol-8497404

We were delighted to take part in the REC’n’Play event in Recife, Brazil (https://recnplay.pe/), contributing to a rich roundtable discussion on innovation in healthcare, exploring new opportunities and perspectives for partnerships between Brazil and France.

Presentation available here: https://uncloud.univ-nantes.fr/index.php/s/eRFxQnbqxw3Ktjk
It was also a great pleasure to share our latest research results on Leishmania CK1 inhibitors (Prof. Pascal Marchand), but also Candida auris (Dr. Isabelle Ourliac-Garnier) during a seminar of the Postgraduate Program in Therapeutic Innovation (PPGIT) at Universidade Federal de Pernambuco, thanks to the kind invitation of Prof. Teresinha Silva and Prof. Moacyr Jesus Barreto de Melo Rêgo.
These 10 years have been marked by inspiring mobilities and fantastic outcomes:
📚 Numerous publications and conference presentations
🎓 7 cotutelle PhD students
🧑‍🔬 4 postdoctoral researchers
🌎 3 MedChem scientific events involving 6 brazilian institutions
A heartfelt thank you to all partners and collaborators who made this journey possible — and to the next decade of shared discoveries and innovation! 😀 🚀

We are pleased to welcome back Nakã Kadri from the Faculty of Science at the université de Sfax - University of Sfax (USS) - Tunisie (Prof. houcine Houcine_Fss Ammar), to the IICiMed Lab! She will be spending six months at Nantes Université working on an exciting project dedicated to developing new heterocyclic compounds as anti-infective agents.
We are also excited to welcome Letizia Frongia from the Università degli Studi di Cagliari, Sardinia - Italy, to our lab! She is joining us for a 3-month Erasmus+ Master’s internship in medicinal chemistry, working on the development of Leishmania casein kinase 1 inhibitors with potential antiparasitic applications. Many thanks to Prof. Elias Maccioni and the Paul Ehrlich MedChem Euro-PhD Network for making this collaboration possible.

Back at IICiMed Lab after an inspiring symposium dedicated to the CK1 kinase family! https://ck1.sci.muni.cz/ MILESTONE International Conference.
A big thank you to Vítězslav Bryja and Marie Doležalová from CEITEC - Central European Institute of Technology Masaryk University, Brno – Czech Republic, for the outstanding organization and warm hospitality.
Prof. Pascal Marchand is proud to have presented our latest research on CTN1122 hit compound and its derivatives as CK1 inhibitors, contributing to the fight against leishmaniasis.

The IICiMed Lab is at RICT2025 in Orléans-France, July 2-4, 2025. This is a fantastic opportunity to share the latest results of the TEXLEISH ANR project, which focuses on CK1 inhibitors as antileishmanial agents.

https://www.rict2025.org/

We are honoured to welcome Assoc. Prof. Florence McCarthy from University College Cork Ireland to the IICiMed Lab for one month, and to announce that he has been awarded the 2025 France Excellence Research Residency grant.

Brazilian collaborators from Universidade Federal de Pernambuco, Recife - Prof. Teresinha Silva, and from Universidade Federal de Alagoas, Maceio - Prof. Thiago Aquino, are also visiting us as part of the CAPES-COFECUB programme.
This is an excellent opportunity to meet their compatriots, Prof. Daniel Assis Santos and Prof. Rafael Bastos, from the Universidade Federal de Minas Gerais and the Universidade Federal do Rio Grande do Norte respectively, who are here as part of another CAPES-COFECUB collaboration managed by Prof. Florent Morio.
Many thanks to Assoc. Prof. Isabelle Ourliac-Garnier for organising such an inspiring meeting with the three networks (PIs, PhD students, postdoctoral researchers, biologists and chemists). Bringing different networks together adds value to scientific exchanges, builds new collaborations and allows us to move forward.
COLLABORATION IS KEY!

The conference, which took place in early June at the School of Pharmacy, was a real success with nearly 170 participants:

https://gp2a.org/index.php/gp2a-2025-paul-ehrlich-medchem-2025-nantes-france-june-11th-to-13th-2025/

In addition to the 8 main conferences, we received 102 abstracts to establish the following programme:
- 17 oral presentations (15 minutes)
- 8 Paul Ehrlich Awards (15 minutes)
- 77 posters: 52 poster presentations (3 sessions) and 25 flash presentations (3 minutes).
17 countries were represented at the conference, with 51 participants in the pre-conference workshop (Artificial Intelligence in Drug Discovery: A New Era of Molecular Design) led by Dr Dylan SERILLON (PharmD, PhD) WhiteLab Genomics, one of our former students.

It was a great pleasure to welcome Assoc. Prof. Vânia Moreira as an invited researcher at the Faculté de Pharmacie de Nantes Université.
Amazing talk dealing with "Anti-infective activities of Abietane-type diterpenoids. A tale of antimicrobial compounds and surfaces" 👏 👏

Last week, IICiMed Lab had the great pleasure of attending the CaPF (Consortium against Parasites and Fungi) conference in Lille.
Many thanks to Faustine Dubar and the local organisers for arranging such a successful event, which brought together biologists, chemists and hospital researchers to discuss human and veterinary health.
We were delighted to present some of the lab's results: 'Candida auris: an emerging multidrug-resistant fungal pathogen' (Prof. Patrice Le Pape) and 'Targeting casein kinase 1 as a novel strategy for the design of anti-infective agents' (Prof. Pascal Marchand).
We look forward to meeting our scientific community again in Strasbourg next year. Prof. Elisabeth Davioud-Charvet-Charvet will be welcoming us.

It was a pleasure to reconnect with Dr. Manu De Rycker at the Drug Discovery Unit, University of Dundee, School of Life Sciences - What incredible facilities! I also had the opportunity to discuss the exciting future directions of the Leishmania casein kinase 1 project, ANR (Agence nationale de la recherche) TEXLEISH, with Prof. Gopal Sapkota from MRC PPU.
A special thank you to Dr. Najma Rachidi from the Institut Pasteur for this valuable collaboration and the opportunity to come and to exchange ideas on our joint projects dedicated to combating neglected tropical diseases.